Literature DB >> 12887051

Molecular regulation of human cathepsin B: implication in pathologies.

Shiqing Yan1, Bonnie F Sloane.   

Abstract

Cathepsin B is a papain-family cysteine protease that is normally located in lysosomes, where it is involved in the turnover of proteins and plays various roles in maintaining the normal metabolism of cells. This protease has been implicated in pathological conditions, e.g., tumor progression and arthritis. In disease conditions, increases in the expression of cathepsin B occur at both the gene and protein levels. At the gene level, the altered expression results from gene amplification, elevated transcription, use of alternative promoters and alternative splicing. These molecular changes lead to increased cathepsin B protein levels and in turn redistribution, secretion and increased activity. Here we focus on the molecular regulation of cathepsin B and attendant implications for tumor progression and arthritis. The potential of cathepsin B as a therapeutic target is also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887051     DOI: 10.1515/BC.2003.095

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  44 in total

1.  Heterogeneity of proteinase inhibitors in the water-soluble organic matrix from the oyster nacre.

Authors:  Laurent Bédouet; Denis Duplat; Arul Marie; Lionel Dubost; Sophie Berland; Marthe Rousseau; Christian Milet; Evelyne Lopez
Journal:  Mar Biotechnol (NY)       Date:  2007-04-03       Impact factor: 3.619

2.  RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.

Authors:  Christopher S Gondi; Neelima Kandhukuri; Shakuntala Kondraganti; Meena Gujrati; William C Olivero; Dzung H Dinh; Jasti S Rao
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

3.  Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation.

Authors:  Lifang Xie; Jerome Terrand; Beibei Xu; George Tsaprailis; Jean Boyer; Qin M Chen
Journal:  Cardiovasc Res       Date:  2010-05-20       Impact factor: 10.787

4.  Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.

Authors:  Jason A Bush; Hideki Kitaura; Yuliang Ma; Steven L Teitelbaum; F Patrick Ross; Jeffrey W Smith
Journal:  Cancer Genomics Proteomics       Date:  2012-01       Impact factor: 4.069

5.  3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.

Authors:  Kamiar Moin; Mansoureh Sameni; Bernadette C Victor; Jennifer M Rothberg; Raymond R Mattingly; Bonnie F Sloane
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

6.  Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.

Authors:  Aron Altorjay; Balazs Paal; Nicolette Sohar; Janos Kiss; Imre Szanto; Istvan Sohar
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

7.  Cathepsin B: Basis Sequence: Mouse.

Authors:  Dora Cavallo-Medved; Kamiar Moin; Bonnie Sloane
Journal:  AFCS Nat Mol Pages       Date:  2011-04-10

8.  A single nucleotide polymorphism CTSB rs12898 is associated with primary hepatic cancer in a Chinese population.

Authors:  Minghua Cui; Quanzhu Chen; Chaojun He; Nan Wang; Yong Yu; Ziyang Sun; Zhenhua Lin; Hesong Cui; Shengyu Jin; Jae Yong Park; Guang Jin; Shin Yup Lee; Qingsong Cui
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

9.  Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.

Authors:  Wan-Nan Chen; Jin-Yan Chen; Bo-Yan Jiao; Wan-Song Lin; Yun-Li Wu; Ling-Ling Liu; Xu Lin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.

Authors:  Rui Zhang; Jiyuan Yang; Monika Sima; Yan Zhou; Jindřich Kopeček
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.